Antenatal HIV screening—ethical considerations

  • P. W. Howie


Antenatal HIV screening has roused much controversy in the medical press. Discussion has centred round whether screening should be offered to all pregnant women or only to those in high risk groups, whether samples sent to the laboratories should be anonymous or identifiable and, most importantly, whether prior consent from the mother is required. It is easy to understand the basis for this controversy because, although antenatal HIV screening has advantages it also creates several problems.


Prevalence Study Antenatal Clinic British Medical Association Prior Consent Anonymous Testing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Doll R. A proposal for doing prevalence studies of AIDS. Br Med J 1987; 294: 244.CrossRefGoogle Scholar
  2. 2.
    Bodmer W, Cox D, Doll R, Durbin. J, Hoffenberg R, Kingman J, Pefo J, Weiss R, Black D. HIV testing on all pregnant women (Letter). Lancet 1987, 2: 1277.PubMedGoogle Scholar
  3. 3.
    Gillon R. Testing for HIV without permission. Br Med J 1987; 294: 821–823.CrossRefGoogle Scholar
  4. 4.
    Declaration of Helsinki. In: The Handbook of Medical Ethics. London: British Medical Association, 1984; pp.73–76.Google Scholar
  5. 5.
    AIDS and the Newborn. Report on a WHO Consultation. Copenhagen, 9–10th April, 1987.Google Scholar
  6. 6.
    Beecham J. Support for BMA council’s decision on AIDS. (Editorial report). Br Med J 1987; 295: 1428–1429.CrossRefGoogle Scholar

Copyright information

© The Royal College of Obstetricians and Gynaecologists 1988

Authors and Affiliations

  • P. W. Howie

There are no affiliations available

Personalised recommendations